Lineage Cell Therapeutics (LCTX) Tax Rate (2014 - 2023)

Lineage Cell Therapeutics' Tax Rate history runs 5 years deep, the most recent figure standing at 29.05% for Q1 2023.

• On a quarterly basis, Tax Rate changed N/A year-over-year to 29.05% in Q1 2023; TTM through Dec 2023 was 7.74%, a 4866.0% decrease from a year earlier, with the FY2025 full-year figure at 7.69%, changed N/A from the prior year.
• Tax Rate grew to 29.05% in Q1 2023 per LCTX's latest filing, from 0.64% in the prior quarter.
• Across five years, Tax Rate topped out at 262.3% in Q4 2019 and bottomed at 8.97% in Q3 2022.
• The 4-year median for Tax Rate is 6.04% (2021), against an average of 37.18%.
• Biggest YoY gain for Tax Rate was 2041 bps in 2022; the steepest drop was 2041 bps in 2022.
• Year by year, Tax Rate stood at 262.3% in 2019, then tumbled by 96 bps to 11.44% in 2021, then sank by 94 bps to 0.64% in 2022, then jumped by 4407 bps to 29.05% in 2023.
• Per Business Quant, the three latest LCTX Tax Rate figures stand at 29.05% (Q1 2023), 0.64% (Q4 2022), and 8.97% (Q3 2022).